Table 5 Susceptibility of the most common gram-negative bacterial isolates tested
Antibiotics | Ampicillin | Amoxicillin-Clavulanic acid | Piperacillin | Piperacillin-Tazobactam | Imipenem | Meropenem | Ertapenem | Cefotaxime | Cefepime | Cefuroxime |
|---|---|---|---|---|---|---|---|---|---|---|
Susceptibility (%) | ||||||||||
GNB (total = 66) | 20.7 | 53.4 | 38.2 | 83.7 | 64.6 | 71.1 | 96.4 | 61.3 | 68.3 | 40.7 |
pseudomonas aeruginosa (27) | 44.4 | 8.3 | 45.8 | 93.75 | 40.7 | 52 | –* | 33.3 | 84 | 0 |
E. coli (20) (ESBL, 10; NON-ESBL, 10) | 22.2 | 77.8 | 0* | 87.5 | 90 | 95 | 94.4 | 58.8 | 50 | 58.3 |
Acinetobacter baumannii (6) | – | 0 | 0 | 16.7 | 16.7 | 20 | – | 0 | 16.7 | 25 |
Klebsiella pneumonia (6) | 0 | 100 | – | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Antibiotics | Ceftriaxone | Ceftazidime | Ciprofloxacin | Levofloxacin | Trimethoprim-Sulfamethoxazole | Gentamicin | Tobramycin | Amikacin | Nitrofurantoin | Colistin |
|---|---|---|---|---|---|---|---|---|---|---|
Susceptibility (%) | ||||||||||
GNB (total = 66) | 34.3 | 64.5 | 43.5 | 26.7 | 58.3 | 61.7 | 40.6 | 71.2 | 93.75 | 91.7 |
pseudomonas aeruginosa (27) | 7.7 | 76 | 40 | 21.4 | 100* | 52 | 42.3 | 44.4 | – | 93.3 |
E. coli (20) (ESBL, 10; NON-ESBL, 10) | 46.2 | 50 | 30 | 25 | 36.8 | 70 | – | 95 | 92.9 | 66.7** |
Acinetobacter baumannii (6) | 0 | 16.7 | 16.7 | 0 | 100 | 33.3 | 25 | 100* | – | 100 |
Klebsiella pneumonia (6) | 100 | 100 | 100 | 100* | 100 | 100 | – | 100 | 100 | – |